NYSE - Nasdaq Real Time Price USD

Baxter International Inc. (BAX)

41.02 +0.62 (+1.53%)
At close: April 23 at 4:00 PM EDT
41.35 +0.33 (+0.80%)
After hours: April 23 at 7:58 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Jose E. Almeida Chairman of the Board, President & CEO 3.62M -- 1962
Mr. Joel T. Grade Executive VP & CFO 829.82k -- 1971
Ms. Heather Knight Executive VP & Group President of Medical Products and Therapies 1.63M -- 1972
Mr. Alok Sonig B.E., Mba Executive VP & Group President of Pharmaceuticals 1.56M -- 1972
Mr. Christopher A. Toth Executive VP & Group President of Kidney Care 5.26M -- 1980
Ms. Tobi Karchmer M.D., M.S. Senior VP and Chief Medical & Scientific Officer -- -- --
Ms. Clare Trachtman Vice President of Investor Relations -- -- --
Mr. David S. Rosenbloom Executive VP & General Counsel 776.51k -- 1960
Ms. Stacey Eisen ?Senior Vice President, Chief Communications Officer & Corporate Marketing? -- -- --
Ms. Jeanne K. Mason Ph.D. ?Executive VP & Chief Human Resources Officer 1.99M -- 1956

Baxter International Inc.

One Baxter Parkway
Deerfield, IL 60015
United States
224 948 2000 https://www.baxter.com
Sector: 
Healthcare
Full Time Employees: 
60,000

Description

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Corporate Governance

Baxter International Inc.’s ISS Governance QualityScore as of April 1, 2024 is 6. The pillar scores are Audit: 6; Board: 6; Shareholder Rights: 1; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 02, 2024
Baxter International Inc. Earnings Call

Related Tickers

BDX Becton, Dickinson and Company
234.36
+0.21%
 
ALC Alcon Inc.
80.76
+0.19%
 
TFX Teleflex Incorporated
211.11
+1.85%
 
COO The Cooper Companies, Inc.
91.68
+1.82%
 
BLCO Bausch + Lomb Corporation
14.85
+1.43%
 
HOLX Hologic, Inc.
77.19
+1.27%
 
EMBC Embecta Corp.
10.88
+1.49%
 
XRAY DENTSPLY SIRONA Inc.
30.86
+1.61%
 
RMD ResMed Inc.
184.22
+2.15%
 
NVST Envista Holdings Corporation
20.22
+0.55%